Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1988 Nov;85(21):8355–8359. doi: 10.1073/pnas.85.21.8355

Dynamic determination of kinetic parameters for the interaction between polypeptide hormones and cell-surface receptors in the perfused rat liver by the multiple-indicator dilution method.

H Sato 1, Y Sugiyama 1, Y Sawada 1, T Iga 1, S Sakamoto 1, T Fuwa 1, M Hanano 1
PMCID: PMC282431  PMID: 2903504

Abstract

Hepatic elimination of epidermal growth factor (EGF) via receptor-mediated endocytosis was studied by a multiple-indicator dilution method in the isolated perfused rat liver, in which cell polarity and spatial organization are maintained. In this method EGF was given with inulin, an extracellular reference, as a bolus into the portal vein, and dilution curves of both compounds in the hepatic vein effluent were analyzed. Analysis of the dilution curve for EGF, compared with that for somatostatin, which showed no specific binding to isolated liver plasma membranes, resulted as follows: (i) both extraction ratio and distribution volume of 125I-labeled EGF decreased as the injected amount of unlabeled EGF increased; (ii) the ratio plot [ln (inulin/EGF) versus time] of the dilution curve for EGF exhibited an upward straight line initially for a short period of time (approximately equal to 10 sec), whereas the ratio plot [ln (inulin/somatostatin) versus time] of somatostatin gradually decreased. The multiple-indicator dilution method was used for other peptides also. Insulin and glucagon, known to have hepatocyte receptors, behaved similarly to EGF in shape of their ratio plots. Thus, analysis of dilution curves can reveal whether or not the cell surface has receptors for certain peptides. In addition, the dilution curves for EGF at various doses (tracer approximately equal to 30 micrograms) were analyzed simultaneously based on a kinetic model incorporating the perfusion rate, the association rate constant of EGF to surface receptors (kappa on), the dissociation rate constant of EGF from the EGF-receptor complex (kappa off), and the sequestration rate constant of the complex. The kinetic parameters [the dissociation constant (Kd = kappa off/kappa on) and the number of surface receptors] calculated by this analysis were comparable with reported values obtained by in vitro direct binding measurements at equilibrium using liver homogenates. We conclude that the multiple-indicator dilution method is a good tool for analyzing the dynamics of peptide hormones--cell-surface receptor interaction under a condition in which spatial architecture of the liver is maintained.

Full text

PDF
8355

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Conlon J. M., Whittaker J., Hammond V., Alberti K. G. Metabolism of somatostatin and its analogues by the liver. Biochim Biophys Acta. 1981 Oct 12;677(2):234–242. doi: 10.1016/0304-4165(81)90090-8. [DOI] [PubMed] [Google Scholar]
  2. Dunn W. A., Hubbard A. L. Receptor-mediated endocytosis of epidermal growth factor by hepatocytes in the perfused rat liver: ligand and receptor dynamics. J Cell Biol. 1984 Jun;98(6):2148–2159. doi: 10.1083/jcb.98.6.2148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Goldstein J. L., Anderson R. G., Brown M. S. Coated pits, coated vesicles, and receptor-mediated endocytosis. Nature. 1979 Jun 21;279(5715):679–685. doi: 10.1038/279679a0. [DOI] [PubMed] [Google Scholar]
  4. Goresky C. A., Bach G. G., Nadeau B. E. On the uptake of materials by the intact liver. The transport and net removal of galactose. J Clin Invest. 1973 May;52(5):991–1009. doi: 10.1172/JCI107300. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. HUNTER W. M., GREENWOOD F. C. Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature. 1962 May 5;194:495–496. doi: 10.1038/194495a0. [DOI] [PubMed] [Google Scholar]
  6. Izzo J. L., Roncone A. M., Helton D. L., Izzo M. J. Subcellular distribution of intraportally injected 125I-labeled insulin in rat liver. Arch Biochem Biophys. 1979 Nov;198(1):97–109. doi: 10.1016/0003-9861(79)90399-0. [DOI] [PubMed] [Google Scholar]
  7. Kakutani T., Yamaoka K., Hashida M., Sezaki H. A new method for assessment of drug disposition in muscle: application of statistical moment theory to local perfusion systems. J Pharmacokinet Biopharm. 1985 Dec;13(6):609–631. doi: 10.1007/BF01058904. [DOI] [PubMed] [Google Scholar]
  8. Kim D. C., Sugiyama Y., Satoh H., Fuwa T., Iga T., Hanano M. Kinetic analysis of in vivo receptor-dependent binding of human epidermal growth factor by rat tissues. J Pharm Sci. 1988 Mar;77(3):200–207. doi: 10.1002/jps.2600770304. [DOI] [PubMed] [Google Scholar]
  9. Miyauchi S., Sugiyama Y., Sawada Y., Morita K., Iga T., Hanano M. Kinetics of hepatic transport of 4-methylumbelliferone in rats. Analysis by multiple indicator dilution method. J Pharmacokinet Biopharm. 1987 Feb;15(1):25–38. doi: 10.1007/BF01062937. [DOI] [PubMed] [Google Scholar]
  10. Moriarity D. M., Savage C. R., Jr Interaction of epidermal growth factor with adult rat liver parenchymal cells in primary culture. Arch Biochem Biophys. 1980 Sep;203(2):506–518. doi: 10.1016/0003-9861(80)90208-8. [DOI] [PubMed] [Google Scholar]
  11. O'Keefe E., Hollenberg M. D., Cuatrecasas P. Epidermal growth factor. Characteristics of specific binding in membranes from liver, placenta, and other target tissues. Arch Biochem Biophys. 1974 Oct;164(2):518–526. doi: 10.1016/0003-9861(74)90062-9. [DOI] [PubMed] [Google Scholar]
  12. Pang K. S., Rowland M. Hepatic clearance of drugs. I. Theoretical considerations of a "well-stirred" model and a "parallel tube" model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance. J Pharmacokinet Biopharm. 1977 Dec;5(6):625–653. doi: 10.1007/BF01059688. [DOI] [PubMed] [Google Scholar]
  13. Roberts M. S., Rowland M. A dispersion model of hepatic elimination: 3. Application to metabolite formation and elimination kinetics. J Pharmacokinet Biopharm. 1986 Jun;14(3):289–308. doi: 10.1007/BF01106708. [DOI] [PubMed] [Google Scholar]
  14. Rodbell M., Krans H. M., Pohl S. L., Birnbaumer L. The glucagon-sensitive adenyl cyclase system in plasma membranes of rat liver. 3. Binding of glucagon: method of assay and specificity. J Biol Chem. 1971 Mar 25;246(6):1861–1871. [PubMed] [Google Scholar]
  15. Sahyoun N., Hock R. A., Hollenberg M. D. Insulin and epidermal growth factor-urogastrone: affinity crosslinking to specific binding sites in rat liver membranes. Proc Natl Acad Sci U S A. 1978 Apr;75(4):1675–1679. doi: 10.1073/pnas.75.4.1675. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. St Hilaire R. J., Jones A. L. Epidermal growth factor: its biologic and metabolic effects with emphasis on the hepatocyte. Hepatology. 1982 Sep-Oct;2(5):601–613. doi: 10.1002/hep.1840020515. [DOI] [PubMed] [Google Scholar]
  17. Tsao S. C., Sugiyama Y., Sawada Y., Iga T., Hanano M. Kinetic analysis of albumin-mediated uptake of warfarin by perfused rat liver. J Pharmacokinet Biopharm. 1988 Apr;16(2):165–181. doi: 10.1007/BF01062259. [DOI] [PubMed] [Google Scholar]
  18. Tsao S. C., Sugiyama Y., Sawada Y., Nagase S., Iga T., Hanano M. Effect of albumin on hepatic uptake of warfarin in normal and analbuminemic mutant rats: analysis by multiple indicator dilution method. J Pharmacokinet Biopharm. 1986 Feb;14(1):51–64. doi: 10.1007/BF01059283. [DOI] [PubMed] [Google Scholar]
  19. Wolkoff A. W., Goresky C. A., Sellin J., Gatmaitan Z., Arias I. M. Role of ligandin in transfer of bilirubin from plasma into liver. Am J Physiol. 1979 Jun;236(6):E638–E648. doi: 10.1152/ajpendo.1979.236.6.E638. [DOI] [PubMed] [Google Scholar]
  20. Yachi K., Sugiyama Y., Sato H., Kim D. C., Fuwa T., Iga T., Hanano M. Comparison of specific binding of human epidermal growth factor (EGF) to sinusoidal and bile canalicular membranes isolated from rat liver. J Biochem. 1988 Mar;103(3):448–451. doi: 10.1093/oxfordjournals.jbchem.a122290. [DOI] [PubMed] [Google Scholar]
  21. Yanai S., Sugiyama Y., Kim D. C., Sato H., Fuwa T., Iga T., Hanano M. Binding of human epidermal growth factor to tissue homogenates of the rat. Chem Pharm Bull (Tokyo) 1987 Dec;35(12):4891–4897. doi: 10.1248/cpb.35.4891. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES